Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CISCA: HIPEC and Cytoreductive Surgery in Gastric Cancer
NCT03150628Phase 2Terminated
- Start
- Aug 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in gastric cancer (GC), Peritoneal metastases. Started Aug 2017; status: terminated.
02
Drugs
cisplatin
03
Conditions
gastric cancer (GC)Peritoneal metastases
Beyond the preview
Go deeper on NCT03150628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150628.